docetaxel Deciparticle (Sapu006)
/ Oncotelic, Sapu Nano, GMP Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 17, 2026
Sapu006 Nanoparticle Docetaxel Demonstrates Comprehensive ADME Equivalence and Comparable PK Supporting its Current Dose Escalation Phase 1b Clinical Trial.
(ESMO 2026)
- No abstract available
Clinical • P1 data • Oncology
July 17, 2026
Sapu006- Polysorbate-free docetaxel with doe-optimized formulation supporting phase 1b clinical trial
(ESMO 2026)
- No abstract available
Clinical • P1 data • Oncology
1 to 2
Of
2
Go to page
1